Atreya, RN; Zimmer, M; Bartsch, B et al.
The Molecular Mechanism of Action of Clinically Effective Anti-TNF Antibodies in Inflammatory Bowel DiseasesGASTROENTEROLOGY. Bd. 136. H. 5. 2009 S. A258-A258
Klotz, L; Burgdorf, S; Dani, I et al.
The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.J Exp Med. Bd. 206. H. 10. 2009 S. 2079-89
Weigmann, B; Lehr, HA; Galle, PR et al.
The Transcription Factor NFATC2 Controls Apoptosis and Activation of T Cells By IL-6 in ColitisGASTROENTEROLOGY. Bd. 136. H. 5. 2009 S. A151-A151
Albiero, E; Ruggeri, M; Fortuna, S et al.
THREE NOVEL MUTATIONS IN THE PROLYL HYDROXYLASE DOMAIN PROTEIN 2 GENE OF THE OXYGEN SENSING PATHWAY IN PATIENTS WITH ISOLATED ERYTHROCYTOSISHAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Bd. 94. 2009 S. 352-353
Koehler, BC; Urbanik, T; Vick, B et al.
TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapiesWorld J Gastroenterol. Bd. 15. H. 47. 2009 S. 5934-35
Neurath, MF; Finotto, S
Translating inflammatory bowel disease research into clinical medicineImmunity. Bd. 31. H. 3. 2009 S. 357-61
Atreya, I; Neurath, MF
Understanding the delayed onset of action of azathioprine in IBD: are we there yet?Gut. Bd. 58. H. 3. 2009 S. 325-6
Teufel, A; Galle, PR; Kanzler, S
Update on autoimmune hepatitisWorld J Gastroenterol. Bd. 15. H. 9. 2009 S. 1035-41
Zenker, S; Atreya, I; Becker, C et al.
Vav1 Acts As An Essential Modulator in Colitis Associated Colon CancerGASTROENTEROLOGY. Bd. 136. H. 5. 2009 S. A466-A466
Pol, S; Berg, T; Bonacini, M et al.
VIROLOGICAL RESPONSE AND SAFETY OF BI 201335 PROTEASE INHIBITOR, PEGINTERFERON ALFA 2A AND RIBAVIRIN TREATMENT OF HCV GENOTYPE-1 PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND NON-RESPONSE TO PREVIOUS PEGINTERFERON RIBAVIRINHEPATOLOGY. Bd. 50. H. 6. 2009 S. 10A-11A